Back to mobile site

Sage Therapeutics (SAGE) PT Lowered to $48 at RBC Capital

November 2, 2021 1:54 PM EDT Send to a Friend
RBC Capital analyst Brian Abrahams lowered the price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login